Nodular thyroid disease pathophysiology

Revision as of 14:09, 19 September 2012 by Raviteja Reddy Guddeti (talk | contribs) (Created page with "__NOTOC__ {{Nodular thyroid disease}} {{CMG}} == Overview == == Pathophysiology== * Most thyroid nodules (~90%) are benign. * Multinodular goiter accounts for 42-77%,...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Nodular thyroid disease Microchapters

Home

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nodular thyroid disease from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Fine Needle Aspiration

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nodular thyroid disease pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nodular thyroid disease pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nodular thyroid disease pathophysiology

CDC on Nodular thyroid disease pathophysiology

Nodular thyroid disease pathophysiology in the news

Blogs on Nodular thyroid disease pathophysiology

Directions to Hospitals Treating Nodular thyroid disease

Risk calculators and risk factors for Nodular thyroid disease pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

  • Most thyroid nodules (~90%) are benign.
  • Multinodular goiter accounts for 42-77%, 15-40% are follicular adenomas, 15-20% are cystic and only 6-17% are carcinomas.
    • Multinodular goiters can, however, contain cancer in 1.5 – 3.6% of the cases.
      • They are generally hypofunctioning, and incompletely encapsulated. Fine needle aspiration--abundant colloid and benign follicular cells.
    • Follicular adenomas are usually single lesions with well-developed fibrous capsules. They are primarily classified according to size and degree of cellularity.
      • Microfollicular adenomas are distinguished from carcinomas by their lack of capsular or vascular invasion. Therefore, the diagnosis of follicular CIS does not exist.
        • Approximately 5% of microfollicular adenomas turn out to be malignant.
      • Macrofollicular adenomas are thought not to have malignant potential.
    • Other benign nodules include Hürthle-cell adenomas (of which 5% can turn out to be malignant), and cysts.
  • Even if a nodule is malignant, differentiated thyroid cancer (papillary and follicular), account for 80% of cases, and are associated with a good prognosis.
    • Sub-clinical thyroid cancer is common, with autopsy studies revealing that 6-13% of the population has occult papillary cancer.

References


Template:WikiDoc Sources